What one share of Grace Therapeutics holds
We are focused on developing and commercializing products for rare and orphan diseases that have the potential to improve clinical outcomes by using our novel drug delivery technologies. We seek to apply new proprietary formulations to approved and marketed pharmaceutical compounds to achieve enhanced efficacy, faster onset of action, reduced side effects, more convenient drug delivery and increased patient compliance; all of which could result in improved patient outcomes.
Grace Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.20 |
|---|---|
| Cash and investments | $0.85 |
| Book value | $2.96 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$34.80 | — | — | — | $6.79 |
| 2020 | — | −$14.48 | — | — | — | $6.74 |
| 2021 | — | −$7.96 | — | — | — | $12.82 |
| 2022 | $16.29 | −$1.60 | — | — | — | $14.67 |
| 2023 | — | −$5.71 | — | — | — | $9.14 |
| 2024 | — | −$1.35 | — | — | — | $6.57 |
| 2025 | — | −$0.79 | — | — | — | $4.86 |
| 2026 | — | −$0.47 | — | — | — | $3.99 |
Common questions about Grace Therapeutics
How much does one share of Grace Therapeutics earn?
Over the last 12 months, Grace Therapeutics lost $1.20 for each share.
Does Grace Therapeutics pay a dividend?
Grace Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Grace Therapeutics’s book value per share?
Grace Therapeutics’s book value is $2.96 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Grace Therapeutics have?
Each share of Grace Therapeutics has $0.85 of cash and investments, as of June 30, 2026.
Has Grace Therapeutics bought back shares?
Grace Therapeutics’s share count rose about 1360% from 2019 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.